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Abstract 
THE NATURE AND MEANING OF INSULIN PUMP USE IN EMERGING 
ADULTS WITH TYPE 1 DIABETES 
 
 
Donna G. Hood 
Dissertation Chair: Gloria Duke, Ph.D. 
The University of Texas at Tyler 
December 2012 
 
 
Emerging adults (ages 18-25) with type 1 diabetes are a vulnerable population as 
they transition from the family home and their pediatric healthcare providers and deal 
with multiple competing demands. There is very little literature addressing those in this 
developmental group who use insulin pump technology for diabetes self-management. 
Listening to the voices of emerging adults who use insulin pump technology will increase 
our understanding of their experience and will give health care providers the opportunity 
to develop evidence based practices based on their lived experiences. This qualitative 
research, using the hermeneutic phenomenological approach described by Max van 
Manen, provides a deeper understanding of the day-to-day journey of the emerging adult. 
Four themes represent the essences that were ultimately viewed as strategies used by 
emerging adults as they crossed from adolescence to adulthood with type 1 diabetes and 
an insulin pump. This journey is presented metaphorically as learning to walk a tightrope.  
 
Keywords: type 1 diabetes, insulin pump, CSII, emerging adult, phenomenology, van 
Manen 
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Chapter 1: Overview of the Research 
An estimated 15,000 youth are diagnosed with type 1 diabetes (T1D) each year in 
the United States (Dabelea et al., 2007) and the incidence of T1D is increasing worldwide 
(Harjutsalo, Sjoberg & Tuomilehto, 2008; Patterson et al., 2009; Vehik et al., 2007).  The 
use of continuous subcutaneous insulin infusion (CSII) for intensive diabetes self-
management is becoming increasingly popular across the life span as a tool for self-
management for those with T1D.  Although technology for diabetes self-management 
continues to increase, research into the human experience with this technology has not 
kept pace.  
Emerging adulthood includes persons between the ages of 18-25 years, and has 
been identified as a distinct developmental period characterized by change, exploration, 
and relative independence without the enduring responsibilities of adulthood (Arnett, 
2000). For the emerging adult with T1D, this is a period of competing priorities that may 
detract from their focus on diabetes self-management (Peters & Laffel, 2011). It is during 
these years that the emerging adult typically moves from their childhood home as well as 
from their pediatric healthcare team. In addition, these are the years of poorest glycemic 
control (Bryden et al., 2001; Insabella, Grey, Knafl, & Tamborlane, 2007; Will, Scott, 
Swift, Davies, Mackie, & Mansell, 2003) and the years when diabetes complications 
begin to emerge (Bryden, Dunger, Mayou, Peveler, & Neil, 2003).   
Only recently has this age group begun to receive attention by researchers and 
health care providers (Weissberg-Benchell, Wolpert, & Anderson, 2007). American 
Diabetes Association (ADA) standards of care (2012) stress the importance of team-
based practices that emphasize a patient-centered approach tailored to the patient. The 
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ADA Transitions Working Group (Peters & Laffell, 2011) called for additional research 
during these crucial years of transition.  With very limited empirical research to guide 
recommended practices for those in this developmental period, this phenomenological 
narrative will contribute to the reflective understanding of the lived experience of this 
population. 
Purpose of the Study 
The purpose of this study is to explore the essential meaning of living with an 
insulin pump as an emerging adult with T1D. Listening to the voices of emerging adults 
who use insulin pump technology will increase our understanding of their experience and 
will give health care providers the opportunity to develop evidence based practices based 
on their lived experiences. Participants for this research were 18-25 year olds who had 
been diagnosed with T1D for a minimum of one year and who had been using an insulin 
pump for at least six months.  
Data generated through individual face-to-face interviews were analyzed using 
the hermeneutic phenomenological method as described by van Manen (1990). 
Phenomenological methods can provide the richness and depth that allow both the reader 
and the researcher to uncover the commonalities and idiosyncrasies that lead to greater 
understanding and sensitivity of care. The identification of emerging themes from the 
participant narratives and the back-and-forth descriptive-interpretive writing provide an 
increased understanding of the patterns, needs, concerns, beliefs, and actual practices of 
this age group at this point in time (van Manen, 1990). This comes not through 
generalizations, but from an understanding of how persons make sense of their 
experiences (Myers, 2000). With attention to sensitivity and mindfulness, the 
3 
 
phenomenological researcher searches for a “pathic” understanding using relational, 
situational, corporeal, temporal and actional knowing (van Manen, 2007, p. 20).  
As a registered nurse and nurse educator working with emerging adults for 20 
years and as the mother of a daughter who uses an insulin pump, this study began with a 
personal passion. In preparation for this phenomenological approach, I immersed myself 
into a deeper phenomenologic learning through a summer intensive workshop, 
Qualitative Analysis II: Phenomenological and Narrative/Discourse Methods with Dr. 
Margarete Sandelowski at The University of North Carolina (UNC) at Chapel Hill School 
of Nursing and again the following summer for the 17
th
 Annual Institute in Qualitative 
Research: Writing Qualitative Research Proposals and Reports at UNC. Throughout the 
research process I maintained a personal reflexive journal (Munhall, 2007) in order to 
reflect on my preconceptions prior to interviews and throughout the process of analysis. 
This included my feelings, concerns, struggles, and emerging meanings.  
Introduction of the Articles 
The first manuscript “Continuous Subcutaneous Insulin Infusion for Managing 
Diabetes: Women’s Health Implications” (Hood, 2012), was published as the featured 
continuing nursing education (CNE) article in the refereed, clinical practice journal 
Nursing for Women’s Health. This journal of the Association of Women’s Health, 
Obstetric and Neonatal Nurses (AWHONN) targets professionals who provide nursing 
care for women and provides practical application of evidence on topics important to 
women’s health, obstetrics and neonatal care. The article provides a review of the insulin 
pump literature as it applies to women from emerging adulthood through menopause, and 
provides to practicing nurses essential background information to provide supportive care 
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to clients who use insulin pump technology. This sets the stage for my research study of 
the insulin pump experience of emerging adults.  
The second manuscript entitled “The Nature and Meaning of Insulin Pump Use in 
Emerging Adults with Type 1 Diabetes” is a report of original hermeneutic 
phenomenological research and is prepared for submission to The Qualitative Report. 
This manuscript was developed from an interpretive analysis of nine interviews with 
emerging adults and was written for health care professionals who provide care to this 
age group. It presents four themes that represent the day to day experiences of emerging 
adults as they crossed through the years 18-25 from adolescence to adulthood. This 
journey is presented metaphorically as learning to walk a tightrope.  
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Chapter 2 
Continuous Subcutaneous Insulin Infusion for Managing Diabetes:  
Women’s Health Implications 
Donna G. Hood, MSN, RNC-NIC 
The University of Texas at Tyler 
August 2012 
Abstract 
The use of continuous subcutaneous insulin infusion (CSII), also called insulin 
pump therapy, is increasing for management of type 1 diabetes. This article provides a 
comprehensive background on CSII, reviews recent studies comparing it to multiple daily 
insulin injections, offers strategies to troubleshoot potential problems, and discusses the 
implications of CSII for women’s health across the lifespan. 
 
Keywords: Continuous subcutaneous insulin infusion, diabetes, insulin pump, type 1 
diabetes 
 
 
 
 
 
 
*Permission to include this manuscript was provided (Appendix A). 
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Manuscript 
The use of continuous subcutaneous insulin infusion (CSII), also known as insulin 
pump therapy, is increasing worldwide for management of type 1 diabetes. Potential 
candidates for this type of insulin administration range from infants to older adults, and 
reported estimates indicate that approximately 25 to 41 percent of people with type 1 
diabetes use CSII (Insabella, Grey, Knafl & Tamborlane, 2007; Ying et al, 2011).  
With the increasing prevalence of diabetes in women of childbearing age 
(Lawrence, Contreras, Chen, & Sacks, 2008; Patterson et al., 2009), and the growing 
numbers of people using CSII for their diabetes management, nurses in women’s health 
settings must understand the principles of pump therapy and know how to access the 
resources that provide pump support for our patients.  
This article discusses the benefits of CSII versus insulin injections and the basics 
of pump use, and gives suggestions for troubleshooting potential problems. Concerns 
specific to CSII in women ofchildbearing age women and areas needing additional 
research are also included. 
Diabetes Self-Management with Insulin 
The benefits of intensive insulin therapy, using CSII or multiple daily injections 
(MDI), were demonstrated in the Diabetes Control and Complications Trial (DCCT Trial 
Group, 1993) and continue to be recognized in the follow-up Epidemiology of Diabetes 
Intervention and Complication (EDIC) study (Nathan et al., 2005). A recent meta-
analysis of 20 studies comparing CSII with MDI – which was defined as three or more 
subcutaneous injections of insulin per day- found a lower hemoglobin A1c (HbA1c) in 
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people using CSII compared with MDI, although this difference (0.3%) was relatively 
small (Misso et al., 2010).  
Measuring HbA1c is considered standard care for those with diabetes; it is 
expressed as a percentage that reflects a person’s average glucose for the prior 2 to 3 
months and has been used as the gold standard for measuring glycemic control. The 
typical recommended HbA1c for someone with diabetes is < 7%. The American Diabetes 
Association Standards of Medical Care (ADA, 2011) states that self-monitoring of blood 
glucose (SMBG) should be performed a minimum of three times per day for those using 
CSII. Davidson, Bode, Steed and Hebblewhite (2007) found a significant association 
between improved HbA1c levels and increased frequency of glucose self-monitoring.  
In an effort to continue to improve the potential for glycemic control, a number of 
advances in technology are available to people with diabetes. Progress with insulin 
analog development and insulin delivery and glucose monitoring systems provide people 
with diabetes new tools for greater involvement in their daily self management. However, 
these new tools present new challenges to nurses caring for those with diabetes in both 
acute and community settings.  
Basics of CSII 
CSII was introduced in the 1970’s with an external insulin pump device the size 
of a backpack. Today’s insulin pumps are about the size of a small cell phone and can 
deliver insulin in as small as 0.025 unit increments. Some pumps contain the capability 
for built-in continuous glucose monitoring. Today’s smart pumps are able to calculate the 
necessary bolus dose of insulin based on the individual’s insulin sensitivity (the amount 
of glucose that is lowered by one unit of insulin), the carbohydrate ratio (the number of 
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carbohydrate grams covered by 1 unit of insulin), individual glucose targets, 
carbohydrate grams eaten, and any insulin estimated to be still “active” in the body. 
Although different pumps can have different features, there are pump fundamentals that 
are important for nurses to know. There are two basic pump configurations. Some pumps 
deliver insulin directly from the reservoir through a small cannula that is placed in the 
subcutaneous tissue and programmed by a separate handheld controller. This “patch 
pump” does not require external tubing. Other pumps connect the insulin reservoir to the 
cannula by a thin tube. The battery powered pump is worn clipped to a waistband, placed 
in a pocket, or tucked into clothing. With either type of pump, rapid-acting insulin is 
contained in a reservoir that should be changed by the user, along with the infusion set, 
every 2 to 3 days. 
Insulin pump therapy is designed to imitate physiologic insulin as delivered by a 
healthy pancreas. Rapid acting insulin analogs (lispro, aspart, and glulisine) are used in 
most pumps (Bangstad, Danne, Deeb, Jarosz-Chobot, Urakami & Hanas, 2009). These 
insulins have a rapid onset and shorter duration than regular insulin. Insulin pumps have a 
basal insulin feature that provides a small amount of rapid-acting insulin as background 
insulin delivered every few minutes around the clock. The pump can be programmed to 
vary this basal insulin rate of infusion based on individualized needs of the person (such 
as with the dawn phenomenon, onset of menses, or with strenuous exercise). Typically 
about 40-50% of the total daily insulin is given as basal insulin although there is 
individual variation (Scheiner et al., 2009).  
Bolus insulin delivery is used to correct high blood glucose readings and to give 
the rapid-acting insulin that is needed to cover carbohydrate intake. Cobry et al. (2010) 
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found a meal-time bolus given 20 minutes prior to a meal to be superior to bolus given 
with a meal or 20 minutes after a meal as long as pre-meal glucose is greater than 80 
mg/dL. If an individual’s glucose reading is low (below 80 mg/dL), the bolus can be 
delayed until the time of the meal.  
Newer generation smart pumps calculate meal and correction boluses based on 
individual target blood glucose level, current glucose reading, insulin-to-carbohydrate 
ratio, and insulin sensitivity. These bolus calculators also take into account the calculated 
amount of active insulin or “insulin on board” that is anticipated to still be circulating in 
the individual’s blood stream. The individual is able to accept and deliver the pump’s 
calculation or make a change prior to starting the insulin delivery based on factors such 
as anticipated exercise.  
Insulin pumps have a delivery option that insulin injections do not have. With an 
extended delivery option, the newer insulin pumps can be programmed to deliver the 
insulin bolus over an extended period of time. These “dual wave,” “square wave,” or 
“extended wave” options are designed to fine-tune insulin delivery to match meals that 
may contain carbohydrates consumed with a meal of higher fat content (e.g. pizza) or 
with meals that may be consumed over a longer period of time (e.g. holiday meal or 
business dinner). Another indication for this option is the delayed gastric emptying and 
delayed carbohydrate absorption in the case of diabetic gastroparesis (Heinemann, 2009; 
Zisser et al., 2008). Although there are varied bolus options for individualized fine-tuning 
of insulin, there is limited quality evidence to direct the pump user to the optimal choice 
based on the complex factors of life (Heinemann, 2009).  
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Women’s Health Implications of CSII Across the Lifespan 
Preconception 
The risks of diabetes are significant. In addition to microvascular and 
macrovascular complications, major birth defects have been reported in 5 to 10 percent of 
pregnancies and spontaneous abortions in 15 to 20 percent of pregnancies in young 
women with poorly controlled diabetes before conception and in early pregnancy 
(Centers for Disease Control [CDC], 2011). Preconception care for the women of 
reproductive age with preexisting diabetes has been recommended for the past 35 years, 
but studies find that these recommendations are followed in only one-third to one-half of 
these women (Chen et al., 2007; Temple, 2011).  
The relationship between glucose control, fetal malformations, and spontaneous 
abortions points to the need for improved glucose control before conception (Temple, 
2011). de Valk and Visser (2011) emphasize the importance of optimal insulin therapy 
planning during the preconception visits. Chuang, Velott and Weisman (2009) explored 
pregnancy and preconception health knowledge and attitudes. Most women in their focus 
groups recognized the importance of preconception glycemic control but acknowledged 
that control was difficult. Several women in the study expressed that CSII should be 
implemented for diabetes self-management in preparation for pregnancy.  
The choice for intensive control is between MDI and CSII. The short-acting 
insulin analog aspart, used in CSII and as one component of MDI, has been shown to be 
safe during pregnancy (de Valk & Visser, 2011). Continuous glucose monitoring (CGM) 
has been determined to be a useful tool for lowering HbA1c in  select adults with type 1 
diabetes and a helpful supplement to self- monitoring of blood glucose for those with 
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hypoglycemia unawareness or frequent hypoglycemia (ADA, 2011). The role of 
continuous glucose monitoring in achieving metabolic control for those with insulin 
pumps is still under investigation.  
At this time, real time continuous glucose monitoring uses a sensor, separate from 
an insulin pump insertion site, placed under the skin to measure glucose in the interstitial 
fluid every 1 to 5 minutes. This device requires calibration 2 to 3 times per day with 
standard blood glucose checks, and has a limited lifespan. Continuous glucose monitors 
provide awareness of hypoglycemia or hyperglycemia through an alarm, and have the 
potential to reduce the time spent with blood glucose out of the target range. With certain 
insulin pumps, glucose data can be displayed on the pump screen to assist the user with 
decisions on their balance of food, insulin, and exercise. However, continuous glucose 
monitoring is not tolerated by everyone, and inaccuracy up to 21 percent is reported in 
continuous glucose monitoring readings when compared to plasma glucose (Hermanidies, 
Phillip & DeVries, 2011).  
Even though recent evidence-based guidelines were published by the Endocrine 
Society (Klonoff et al., 2011), research and development of the ideal sensor that will 
provide real time glucose monitoring with a patient-acceptable design is still on-going. 
The use of continuous glucose monitoring may play an important role for the woman 
planning for pregnancy and additional research in this area is needed. 
Glucose Control During Pregnancy  
Balancing glycemic control while minimizing the risk of severe hypoglycemic events 
is essential during pregnancy. However, hypoglycemia is common, particularly during 
the first trimester when there may be increased insulin sensitivity. This increased 
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sensitivity coupled with tight glucose control places the pregnant woman at increased risk 
for hypoglycemia. Hypoglycemia unawareness, a phenomenon when there is a blunting 
of the body’s release of glucagon and epinephrine and the classic symptoms of 
hypoglycemia are not recognized (Beaser, 2007), is also more common during pregnancy 
(Hawthorne, 2011).  
It is essential that pregnant woman with diabetes and the people in their lives, 
recognize the signs and symptoms of hypoglycemia and are familiar with appropriate 
treatment, including the role of glucagon. Severe hypoglycemia - defined as an episode 
requiring the assistance of another person and marked by altered consciousness and 
possible seizure - is a potentially fatal complication and is associated with hypoglycemia 
unawareness (deValk & Visser, 2011). Because signs and symptoms may be missed or 
attributed to changes associated with pregnancy, increasing the frequency of self-
monitoring of blood glucose to six or more times per day is recommended (Hawthorne, 
2011). 
Individual insulin requirements vary. Two additional factors can complicate the 
regulation of insulin levels. After about 20 weeks gestation insulin resistance increases 
and there is often an additional rise in blood sugar and, therefore, a rise in insulin 
requirements between 4 a.m. and 6 a.m. related to the release of cortisol and growth 
hormones (de Valk & Visser, 2011). The potential hyperglycemia from this “dawn 
phenomenon” and the changing basal insulin requirements make the use of CSII with 
individualized programming of different basal insulin delivery rates especially appealing. 
The addition of continuous glucose monitoring provides alarms to alert the individual to 
interstitial glucose readings outside the set limits. Continuous glucose monitoring also 
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stores data reflecting almost continuous glucose changes, and this can assist with the fine-
tuning of insulin requirements and pump settings during pregnancy.  
The American Association of Clinical Endocrinologists (AACE) published a 
consensus statement on insulin pump management that includes a suggested protocol of 
insulin pump use during pregnancy (Grunberger et al., 2010). This protocol addresses 
suggested basal and bolus insulin infusion rates through the stages of gestation, as well as 
recommendations for changes based on time of day.  
Diabetic Ketoacidosis and Pregnancy 
Diabetic ketoacidosis is the result of acute insulin deficiency in a person with 
diabetes and consists of hyperglycemia, ketosis and acidosis (Kisiel & Marsons, 2009; 
Koul, 2009). The resulting dehydration from osmotic diuresis and electrolyte imbalance 
increase the risk for complications and potential death. Although diabetic ketoacidosis is 
not a frequent occurrence, it is a medical emergency and does carry an increased risk to 
both mother and fetus if it occurs during pregnancy (Hawthorne, 2011). A pregnant 
women presenting with nausea, vomiting and persistent hyperglycemia should be 
evaluated for diabetic ketoacidosis (Hawthorne, 2011). Grunberger et al. (2010) 
emphasize that during the state of accelerated ketosis related to pregnancy, a few hours 
without insulin infusion can lead to hyperglycemia and ketosis. 
Labor, Delivery and Postpartum  
There is a paucity of research directing the use of CSII during labor. However, the 
lay literature encourages women to discuss the possibility of continuing CSII with their 
obstetric healthcare providers. The AACE Consensus Statement (Grunberger et al., 2010) 
points out the physical demands of labor and the need for glucose substrate to prevent the 
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depletion of hepatic glycogen stores.  It is important to stress that if the demands of labor 
and delivery result in the patient’s inability to maintain a steady glucose level with 
frequent blood glucose checks and adjustments to insulin pump settings, or if the 
patient’s provider is not familiar with the necessary alterations in insulin adjustments, 
then the patient’s glucose can be managed by the RN with IV insulin infusion.  Patient 
safety can be jeopardized if the patient adjusts her pump without the supervision of her 
provider. Medical supervision is essential, as the patient may be unfamiliar with changes 
in her insulin needs during labor and postpartum, and may end up chasing her blood 
sugar toward either extreme as a result.  
During or immediately after delivery, insulin requirements decrease rapidly. de 
Valk and Visser (2011) recommend decreasing the insulin dose to 25 to 40 percent of a 
woman’s pre-delivery dose to avoid hypoglycemia in both patients who deliver vaginally 
and those who undergo caesarean surgical delivery. Breastfeeding should be encouraged 
and initiated. Insulin analogs can be safely used with lactation, and the health care team 
should note that insulin requirements decrease with breastfeeding, as well (de Valk & 
Visser, 2011). A snack before nursing may be indicated to prevent hypoglycemia. 
Aggressive glucose control can be relaxed a bit during this period to avoid significant 
hypoglycemia (Beaser, 2007). The mother-baby nurses should be alert to signs and 
symptoms of hypoglycemia and recognize that hypoglycemia unawareness is possible 
during the postpartum period.  
The results of the intense efforts toward glycemic control during the 
preconception period and pregnancy may serve as an encouragement and may motivate 
women with type 1 diabetes to continue to seek intensive glycemic control following her 
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pregnancies. The entire health care team should support and encourage their efforts to 
maintain glycemic control from this point on. 
Older Adulthood 
With the improvements in diabetes management over the past years, there are a 
significant number of older adults who were diagnosed with type 1 diabetes earlier in life 
(Rizvi, 2002). Although limited research has been published specific to CSII in this 
population, the Center for Medicare and Medicaid Services now covers CSII use in 
patients with either type 1 or type 2 diabetes who are over 65 years of age and who meet 
specified eligibility criteria (Grunberger et al., 2010; Hainer, 2006).  Improved glucose 
control and decreased hypoglycemic episodes were reported in a small group of older 
patients with type 1 diabetes who switched to CSII from MDI  (Rizvi, Arnold & 
Chakraborty, 2001). Herman et al. (2005) found both CSII and MDI to be effective, safe 
and accepted in older adults with type 2 diabetes requiring insulin therapy. Rizvi (2002) 
pointed out that the use of CSII can even be a possibility in older patients in personal care 
homes and skilled care nursing facilities. With the increasing incidence of type 1 and type 
2 diabetes, growing acceptance of insulin pump therapy, and the aging of the population, 
it is expected that nurses will be working with an increasing number of insulin pump 
patients in various settings and throughout the lifespan. 
CSII in the Inpatient Environment 
Reports indicate that patients who use CSII may be candidates for diabetes self-
management when they are in the hospital setting (ADA, 2011; Bailon et al., 2009; 
Morviducci et al., 2011). These reports stress the importance of having policies and 
procedures in place with guidelines for inpatient insulin pump use, including regular 
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nursing documentation (at least daily) of basal and bolus insulin doses (ADA, 2011). 
Opportunities exist for nurses to take part in policy development and participate in new 
roles such as diabetes resource nurse. Hospital personnel with CSII expertise are 
essential.  
Pump Malfunctions and Implications for Pregnancy 
Chen et al. (2007) compared CSII and MDI in a single-center study of pregnant 
women with preexisting diabetes. They reported no significant differences in maternal 
hypoglycemia events, HbA1c, gestational age at delivery, mean birth weight or cesarean 
rate. They did find a significantly higher rate of mild diabetic ketoacidosis in the CSII 
group (4 of 30), with all cases due to reported pump failure. 
Even with the ongoing advances in CSII, pump malfunctions are a possibility that 
nurses and patients should anticipate. Guilhem et al. (2009) reported their findings from a 
study of pump failures in adults with type 1 diabetes. They reviewed 640 pumps from 
four pump manufacturers during the years 2002-2007 and found 36 percent of pumps 
encountered a mechanical malfunction. Of these cases, 17 percent resulted in 
hyperglycemia and one case was believed to have resulted in severe hypoglycemia. No 
participants required hospitalization related to pump malfunction during the study period. 
Troubleshooting Potential Problems 
The AACE recently released a consensus statement on insulin pump management, 
which emphasized the importance of a comprehensive pump management approach for 
all practices treating patients who use insulin pumps (Grunberger et al., 2010). In 
addition, everyone with an insulin pump should have around-the-clock access to support, 
should pump problems arise. These resources are also available to nurses caring for pump 
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users. Pump manufactures have staff available for ongoing technical support via 24/7 
help lines. The help line number is located on the back of the pump device and on the 
product website. Additional detailed written or video instructions can be found on the 
product websites. 
Troubleshooting problems with insulin pump therapy requires that clinicians be 
familiar with common problems. A pump should not be removed for more than 1 hour at 
a time, unless rapid acting insulin is given as an injection. Because insulin pumps deliver 
only rapid-acting insulin, any interruption in insulin delivery or insulin absorption risks 
hyperglycemia and the potential for diabetic ketoacidosis. If hyperglycemia is 
accompanied by ketosis, vomiting or alteration in consciousness, the diabetes care team 
should be contacted immediately (ADA, 2011).  
Issues of hyperglycemia may be related to numerous factors. The stress of illness, 
trauma, or surgery may result in hyperglycemia and may precipitate diabetic ketoacidosis 
(ADA, 2011). Some women report hyperglycemia and difficulty with glucose control 
associated with menses. Ramalho, Andrade & Prates (2009) reviewed the literature on 
glucose control and the menstrual cycle and found no consensus related to glycemic 
variation in the limited number of published studies to date.  
In addition, there may be a problem with insulin delivery. Ask the patient about 
the insulin itself. Opened vials of insulin may be left at room temperature if used within 
4weeks (Bangstad et al., 2009). This 4-week guideline considers issues for sterility and 
clinical potency. Unopened vials of insulin should be stored in a refrigerator (36°- 46° F) 
and may be used until the expiration date printed on the box. Insulin should never be 
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frozen. In hot climates insulin may become damaged and should be changed if the insulin 
or pump has been exposed to temperatures > 98.6° F. 
Trouble can result from the site of the insulin infusion. The patient needs to place 
the infusion cannula in an area that has not been exposed to insulin infusion for a number 
of days. Pump guidelines state that soft cannulas made of Teflon can remain in the 
subcutaneous site for up to 72 hours (Scheiner et al., 2008). Tissue irritation and 
lipodystrophic changes in the subcutaneous tissue can occur if insulin infuses into the 
same region of skin for a prolonged period of time. As a result, insulin absorption may 
diminish, although this is a scenario that has not been well-studied (Heinemann, 2009).  
To troubleshoot glucose readings that remain high despite delivery of 
recommended insulin, ask your patient how long the cannula has been in the current site. 
Also ask about her site rotation. If she uses only two sites and rotate back and forth, lack 
of insulin absorption due to lipodystropic changes could be the issue.  
Insulin pumps have several safety check features. Giving a bolus dose of insulin 
requires the user to confirm the dose with some pushes of a few buttons. The dose is not 
delivered unless the dose is confirmed. If there is unexplained elevated blood glucose, 
check the bolus history to verify that the intended dose was delivered. The pump alarms 
to alert the wearer to an occlusion; however, it is possible to have the insulin leak out 
from a poor connection between the tubing and the cannula without an alarm. It is also 
possible to have the infusion cannula come out of the skin (think about a laboring patient 
or an active child). The pump could be delivering insulin, but it is not going into the 
subcutaneous tissue and is therefore not available to the body. 
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What the Future Holds 
Supporting today’s women with diabetes requires nurses and other health care 
providers to understand the basics and the possibilities of CSII. As the number of people 
with preexisting diabetes increases and technology continues to improve, there is need for 
randomized controlled trials to determine best practices for women during pregnancy, 
labor and deliver, and the postpartum period, as well as CSII use in the years following 
menopause. 
Although CSII was designed for use in people with type 1diabetes, the use of 
insulin pumps with type 2 diabetes is receiving more attention. As patients with type 2 
diabetes face declining beta cell function, most will require insulin therapy to provide 
glycemic control (Holman et al., 2009). Recent studies have not found CSII to be 
clinically superior to insulin injections; however, overall preference for CSII was 
reported by study participants due to convenience, flexibility and ease of use (Bode, 
2010). Research and development of simpler insulin pumps and protocols for the 
population of patients with type 2 diabetes is in progress.  
Work is on-going with efforts for a closed-loop system or “artificial pancreas.” 
This system would consist of continuous glucose monitoring, an insulin pump and a 
controlling device using individualized algorithms to control insulin delivery. This 
sensor-augmented pump would automatically suspend basal insulin in response to low 
glucose readings (Choudhary et al., 2011).  
Other potential technology may include combining insulin and glucagon delivery 
and the use of intraperitoneal insulin delivery. An experimental version of the artificial 
pancreas was recently tested in 10 pregnant women with type 1diabetes in the hospital 
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setting. This study reported positive glucose control overnight, but issues remain in 
adequate control after ingestion of high carbohydrate meals (Murphy et al., 2011). 
As the technology evolves and acceptance of advanced methods for diabetes self- 
management increase, so must research to direct best practices in all settings. From the 
best ways to fine-tune insulin delivery based on individual lifespan variations, to policies 
and procedures to support CSII in hospitalized patients, opportunities for research and 
quality improvement are available for the health care team. 
Conclusion 
Optimizing glycemic control before, during, and after pregnancy is critical to 
minimize maternal and fetal risks, and is important for people of all ages with diabetes. 
CSII is an important tool to assist with diabetes self management. As the population 
using insulin pump technology continues to increase and evidence-based practice 
guidelines are developed for CSII in inpatient and outpatient settings, it is necessary for 
nurses to become familiar with the basics of insulin pump use. Amid the growing 
complexity of health care, nurses must stay current with the rapid changes in technology.  
Every patient encounter is an opportunity to encourage and motivate those with 
the on-going challenges of chronic illness, such as diabetes. Optimal diabetes 
management requires the collaboration of an up-to-date, patient-focused team. Nurses 
play a vital role on this team. Taking the opportunity to learn from our patients and the 
ongoing research in this field will provide personal professional growth and promote 
optimal care for women with diabetes.  
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Chapter 3 
The Nature and Meaning of Insulin Pump Use  
in Emerging Adults with Type 1 Diabetes 
Abstract and manuscript prepared for The Qualitative Report 
Abstract 
Purpose: The purpose of this study is to investigate the multidimensional meaning of 
living with an insulin pump for the management of type 1diabetes while facing the 
challenges of life as an emerging adult. Through a phenomenological narrative, this study 
contributes to the reflective understanding of the everyday life experience of this 
population.  
Methods: A hermeneutic phenomenological design was used for this study of nine 
emerging adults (age 19-24 years). Data was generated through face-to-face interviews 
and analyzed by the phenomenological approach of Max van Manen. 
Results: Four themes represent the essence of day to day experiences of these emerging 
adults: seeking control, becoming responsible, staying connected, and accepting me. 
Conclusions: A thorough and in-depth understanding of the meaning of daily 
experiences with insulin pump technology has the potential to impact how we provide 
care to these emerging adults. The human understanding gained through this study is 
essential to the development of evidence-based practice guidelines and resources for this 
vulnerable population.  
Keywords: type 1 diabetes, insulin pumps, emerging adults, young adults, 
phenomenology, van Manen 
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Manuscript 
Emerging adulthood has been identified in industrialized countries around the 
world as a distinct developmental period between adolescence and adulthood (Arnett, 
2000). For those emerging adults with type 1 diabetes (T1D), this period has been 
identified as a time when glycemic control is at its worst (Bryden et al., 2001; Insabella, 
Grey, Knafl & Tamborlane, 2007; Will et al., 2003). According to the recent SEARCH 
for Diabetes in Youth study, approximately 15,000 youth are diagnosed with T1D in the 
United States every year (Dabelea et al., 2007), and data suggest that the incidence of 
T1D is increasing in the US and worldwide (Patterson, Dahlquist, Gyurus, Green & 
Soltesz, 2009; Vehik et al, 2007).  
The period spanning adolescence through young adulthood is critical for diabetes 
control (Sparud-Lundin, Öhrn & Danielson, 2010) and is significant for both the 
emerging adult and the healthcare team as the emerging adult makes the transition from 
both the family home and their pediatric diabetes care team (Daneman & Nakhla, 2011; 
Peters & Laffel, 2011; Weissberg-Benchell, Wolpert, & Anderson, 2007). It is during 
these years that independent routines of self-care are established (Anderson & Wolpert, 
2004). Bryden, Dunger, Mayou, Peveler & Neil (2003) in their longitudinal cohort study 
of 17-25 year-olds, found an alarming number of young adults (28-37 years) with clinical 
complications and psychiatric concerns. In addition, young women with T1D who do not 
have excellent glycemic control prior to conception have a much higher risk of congenital 
malformations and pregnancy loss than women without diabetes (Kitzmiller, Wallerstein, 
Correa & Kwan, 2010; Mills, 2010; Pearson et al., 2007). Weissberg-Benchell, Wolpert,  
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and Anderson (2007) proposed using the theoretical model of emerging adulthood 
(Arnett, 2000) as a framework for research with this vulnerable age group with T1D.  
Continuous subcutaneous insulin infusion (CSII), also known as insulin pump 
therapy, is used by approximately 25-41% of individuals with T1D (Insabella et al., 2007; 
Ying et al, 2011). A meta-analysis of insulin pump studies found improvements in 
glycemic control and a reduction in severe hypoglycemia with insulin pump therapy 
(Pickup & Sutton, 2008), however few studies have assessed any aspect of psychosocial 
functioning in pump users.  No studies were located that specifically examined the insulin 
pump experience in the emerging adult population in the United States. Although more 
intensive regimens with significant improvements in technology have become more 
common internationally, we have yet to fully understand why glycemic control continues 
to be an issue for this age group (Hoey, 2009; Hood, Butler, Volkening, Anderson & 
Laffel, 2004; Insabela et al., 2007; Weissberg-Benchell, Wolpert, & Anderson, 2007). 
The purpose of this study was to investigate the multidimensional meaning of living with 
an insulin pump while facing the challenges of life as an emerging adult. Through a 
phenomenological narrative, this study contributes to the reflective understanding of the 
everyday life experience of this population. A thorough and in-depth understanding of the 
meaning of daily experiences with insulin pump technology has the potential to impact 
how we provide care to these emerging adults. The human understanding gained through 
this study is essential to the development of evidence-based practice guidelines and 
resources for this vulnerable population.  
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Methods 
Research Question and Phenomenological Approach 
This research was conducted using the hermeneutic phenomenological method as 
described by van Manen (1990). Phenomenological methodology focuses on questions 
that address the way we experience the world in everyday life. In this study, I met with 
emerging adults who were engaged in their daily experiences with insulin pumps in their 
homes or on the university campus where they attended classes. Arnett’s developmental 
theory of emerging adulthood (Arnett, 2000) and van Manen’s (1990) lifeworld 
existential experiences of lived time (temporality), lived space (spatiality), lived body 
(corporality), and lived human relations (sociality) were used to provide the contextual 
richness and depth of interpretation that produced an expanded understanding of the 
patterns, needs, concerns, beliefs, and actual practices of this age group at this point in 
time. The research question for this study was: What is the meaning and significance of 
insulin pump use for emerging adults with type 1 diabetes? 
Sample and Participant Selection 
Participants were solicited in two southern states of the United States in person by 
the researcher and through letters from the researcher distributed by area diabetes 
educators. A purposive sample of nine emerging adults (between ages 18-25) reporting a 
diagnosis of T1D for a minimum of one year, and who had been using an insulin pump 
for diabetes self-management for at least six months, was adequate to reach information 
redundancy. Recruitment of participants took place between December 2011 and June 
2012. The average age of participants was 20.9 years (range 19-24 years). They had lived 
with T1D for an average of 12.5 years (4.5-21 years), and used insulin pumps at an 
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average of 7 years (2.5-11 years). Six participants were female, three were male, and all 
were Caucasian. Their time demands ranged from full time employment to full-time 
student and part-time employment, to seeking a job. None of the participants lived alone. 
One participant lived at home with parents and one was married. Seven participants lived 
in apartments with roommates. The participants’ last self-reported HbA1C ranged from 
6.1% to12%. The initial pump management for these participants was supervised by 
pediatric endocrinology practices in five southern states (Oklahoma, Texas, Arkansas, 
Louisiana, and Tennessee).  
Protection of Human Subjects 
The research proposal was approved by The University of Texas at Tyler 
Institutional Review Board (IRB) (Appendix B) and Louisiana Tech University IRB 
before implementation. Written informed consents (Appendix C) were signed by 
participants after validation of their understanding of the study. A $25 gift card was given 
to participants to help compensate for their time. 
Data Collection Procedure 
A reflective journal was begun before initiating interviews to facilitate recognition 
of personal presuppositions and biases that existed due to researcher roles as a pediatric 
nurse, a university faculty member, and as a mother of an adolescent who uses an insulin 
pump. Journaling continued throughout the data generation and analysis process. 
Participants were asked to select a face-to-face interview location that would be quiet and 
comfortable for them. Interview locations included their home, a friend’s home, and a 
university office. After providing written informed consent and selecting a pseudonym of 
their choice, the participant was asked to complete a brief demographic questionnaire 
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(Appendix D). The pseudonym was used during the interview and on the questionnaire in 
order to facilitate confidentiality of the transcripts.  Interviews were recorded using an 
audio digital recording device. A semi-structured interview guide was used as a 
foundation for the interviews (Appendix E). As the participant responded to these 
questions, probes were used to gain a deeper understanding of their experiences as an 
insulin pump user in their university and/or work environments. Interviews ranged from 
33 to 68 minutes (average 56 minutes).  Immediately following each interview the 
researcher recorded field notes describing the setting, observations, interactions, and 
initial impressions to provide contextual information to augment the textual data. 
Data Management and Analysis  
Audio recordings were transcribed and transcripts were compared with the 
recording for accuracy by the researcher. The dynamic methodological process of 
thematic analysis, as described by van Manen (1990) guided this study. Individual 
transcripts and field notes were initially read in order to gain a sense of general holistic 
meanings from the interview.  The transcripts were then analyzed line-by-line with key 
words and phrases highlighted and interpretive notes recorded on the transcripts. Audio 
transcripts were re-played for further reflection of key findings for each transcript. These 
initial meaning units were grouped and re-grouped across transcripts through a process of 
writing and re-writing until essential themes that reflected the meaning of insulin pump 
use for these participants were identified. Each transcript was read with attention to the 
impact of their experiences on their body, time, space, and relationships with others 
(Appendix F).  A second researcher, experienced in phenomenological research, 
reviewed and suggested revisions in the coding which were accepted by the principal 
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investigator.  Through an iterative process of writing and re-writing four final themes 
were identified that expressed the meaning of insulin pump use to these emerging adults. 
Trustworthiness 
Several strategies were used to ensure rigor in this study. The research proposal 
was evaluated by four qualitative researchers for appropriateness of research question, 
method, sampling criteria and analysis. All verbatim transcripts were reviewed with the 
audio recording by the researcher for accuracy. Field notes, made by the researcher 
immediately following each interview, provided additional richness to the data and were 
used in analysis. A second experienced researcher provided inter-rater reliability by 
reviewing initial coding of data and the identification of initial sub-themes. 
Reflexivity through the researcher’s on-going written reflections in a research journal 
provided a way to continually identify personal perspectives and to compare them with 
the iterative process of interpretation of meaning. This means of promoting mindfulness 
began prior to the initial interview and was on-going throughout the writing process. The 
research journal, coded transcripts, and drafts of the narratives provided an audit trail that 
was reviewed by the researcher’s dissertation chairman to follow the iterative process that 
resulted in the final determination of the four themes of this study. 
The narrative findings were reviewed by an emerging adult with an insulin pump who 
was not a study participant who verified that the findings resonated with her life 
experiences. A summary of the findings was sent to participants for member check. 
These participants concurred that the finding accurately reflected their experiences.  
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Findings 
The journey through life with type 1 diabetes (T1D) is much like the process of 
learning the art of tightrope walking. Like living with diabetes, learning this art unfolds 
over time and requires the walker to return to the wire after inevitable falls. Tools can be 
used to help the walker maintain balance because tightrope walking requires the walker 
to respond to the slightest disturbance. CSII, also known as insulin pump therapy, is one 
of those balancing tools for someone with T1D. The lived experience of the emerging 
adult who has T1D and uses an insulin pump was represented as four primary strategies. 
These strategies were the tools they learned to use to maintain balance in life during the 
years spanning adolescence through young adulthood when the “tightrope” had been 
raised to a new level of elevation. They included: seeking control, becoming responsible, 
staying connected, and accepting me. Pseudo-names are used for direct quotes. 
Seeking Control 
Transitioning to the insulin pump meant hope for control as the emerging adults 
began using this sophisticated technological tool to gain control of their blood glucose 
(BG) and to regain control of their lives. Participants found themselves battling new 
variables in the university environment. They encountered vulnerability when they lost 
BG control and recognized that multiple factors must be considered in order to gain the 
control that they wanted.   
Regaining control of life. Two participants made the transition just before 
starting college because of persistent difficulty with glucose control. Both had been 
encouraged to go to the pump earlier, but resisted until this point.   
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I had resisted my parents for years and years. I did not [emphasis added] want a 
pump. I hated the sound of a pump, the sound of anything – a needle, a catheter 
tube – to have anything attached to me 24/7 scared me to death (Anne).  
These participants found that in gaining control of their BG, they also re-gained 
control of their lives and were glad to have the convenience and freedom that the insulin 
pump provided, “loved it . . . hated I waited as long to get it.” They had the freedom to 
eat when their friends were eating and to enjoy the spontaneous lifestyle of a typical 
university student. “It opened me up to do what I wanted when I wanted to” (Jim). 
However, even with the benefits of the insulin pump, keeping blood glucose (BG) levels 
in control was an elusive quest for the emerging adult. 
Battling the variables.  Transitioning to the university environment with T1D 
meant attempting to maintain balance as the emerging adult faced multiple variables that 
influenced their BG control. The daily balancing act of dealing with changing schedules, 
stressful exams, frustrating roommates, late night studying, and evolving new 
relationships continually challenged their efforts to maintain BG control. “If I’m stressed 
out, it’ll skyrocket . . . my menstrual cycle, it’ll jump.” Participants repeatedly described 
their experience as “every day is different.”  Amy described her BG challenge as “You 
can eat the same thing for breakfast, lunch and dinner every day and you can be low one 
day and you can be high another.” Frustration was common when BG was running high 
and they had no idea why. Despite the lack of stability, using the pump brought a sense of 
hope. They had a tool with the potential for control. 
Encountering vulnerability. Although BG control was desired, scary episodes of 
severe low and high BG brought the emerging adult face to face with their vulnerability. 
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Episodes of hypoglycemia were particularly frightening to the emerging adult. One 
participant described through her tears a severely low BG episode that occurred during 
her first year in college.   
I kept getting lower and lower and my pod just automatically gives me [basal 
insulin]. My boyfriend called me and I don’t even remember talking to him.  I 
didn’t know where I was or what time of day it was. That was like 3 o’clock in 
the afternoon and I was still asleep. . . I couldn’t stand up. I was trying to get to 
the bathroom because in my mind I was like ‘I need to take a shower. I need to 
get ready.’ . . . My roommate knocked on the door and I somehow managed to get 
over there and she asked me if I was drunk. I was like, ‘No.’ I don’t even drink, 
you know. I was laughing, but I was so scared when I actually came to. She 
started crying and she called her mom. . . When I finally came to, I realized what 
happened and like, the chair in my room was knocked over and a picture frame 
was broken. . . a bowl was completely shattered. . . It was real scary. My mom 
was completely beside herself. . . I was exhausted because of what had happened 
with my body. (Hannah) 
Even though Hannah notified her physician so that pump changes could be made, 
her fear instigated a new routine for her. “[I would] usually go to bed with my blood 
sugar like almost to the 200’s just because I was scared that it’d get so low.” The 
challenge of maintaining tight BG control was at times at odds with the need to be in 
control.  
A sense of vulnerability also accompanied episodes of unexplained 
hyperglycemia. The fear experienced with extremely high BG values that were not 
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responsive to insulin boluses and infusion set changes brought heightened concern over 
“what next?”  High BG could occur rapidly with insulin pump troubles and could also 
result in the participant’s BG plummeting to dangerous low levels as they faced 
vulnerability from both extremes. Burt reflected this concern when hospitalized for 
diabetic ketoacidosis (DKA) and felt his BG dropping to a scary level.  
I had to get my dad to go get me something to eat. They [nurses] wouldn’t listen 
to me. . . It’s dangerous, you know? You can die from this. That surprised me 
though, when I first went to the hospital and woke up. Like, they didn’t know 
about it as much as I did. 
Controlling placement and infusion set changes.  Using the pump meant facing 
the on-going challenge and frustration of changing the infusion set.  Current insulin pump 
technology requires changing the insulin infusion set every 2-3 days. Initial use of the 
pump often required gaining control over fear of pain associated with the infusion set 
changes. Burt, age 20 described his grandmother’s tactic of bribery and “numbing cream” 
to “break me of being scared.”  Although there are devices that assist with the insertion 
process, inserting the infusion set carries a sense of reluctance and “sometimes . . . the 
button gets harder to press.”  
Individual control over infusion set or pod placement was influenced by physical 
restrictions such as limited subcutaneous tissue or tissue changes that can result from 
years of pump use with limited site rotation. Practical restrictions such as difficulty 
reaching potential sites or discomfort from constant bumps of the infusion set from 
backpacks or jeans were challenges as were social concerns, such as visible bulges or 
exposed tubing. Trying new sites that were different from the comfortable, familiar 
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locations met resistance from the participants. These emerging adults typically waited to 
change infusion sets only when insulin in the reservoir was empty or almost empty or 
when BG readings were consistently high. Time constraints, economic concerns, comfort 
issues, and a general sense of dread came into play as primary motivators for delaying 
site changes for as long as possible.  
Becoming Responsible 
Just as the tightrope walker learned the art through a series of progressive steps, 
becoming responsible for diabetes self-care began as a gradual shift. Major markers 
occurred during the high school years such as gaining a driver’s license and increasing 
independence from parents. Although these markers served as preludes for the transition 
to university life, the epiphany of suddenly feeling “on my own” came after moving from 
home and facing the “everydayness” of a chronic and potentially life-threatening disease 
that required on-going attention. With some, the epiphany came when they faced the 
reality of complications and the realization that “it was all me now." The tightrope walk 
to adulthood was a process of accepting more responsibility. 
Thinking ahead: I still have diabetes. Enjoying the freedom that is possible with 
insulin pump technology required accepting responsibility for planning ahead to be sure 
there was enough insulin in the reservoir, enough battery life in the pump, a cool place 
for the insulin in the heat of the summer, and sufficient back-up supplies just in case they 
were needed. These emerging adults were beginning to understand that life with a pump 
meant planning ahead for where they would be and what they would be doing. Daily 
living activities of going to classes, to work, to long music or sports-related practices, or 
out of town for the weekend necessitated proactive planning.  This understanding came 
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with experience. Anne described how she learned the hard way when she transitioned 
from college classes to work and realized she could not "just go home" for batteries, 
insulin, or a new infusion set. Stuck at work and unable to contact anyone for help, she 
described how her BG steadily increased until she got “sick as a dog.” Now she has all of 
her necessary pump supplies as backup in her office.  She and the other emerging adults 
recognized that in not accepting this responsibility, they would put themselves at risk.  
Remembering and doing: I forget, but diabetes is never really forgotten.  
Enjoying the freedom a pump can provide also meant accepting responsibility for self-
management tasks. Burt shared, “(the pump) is such a great tool that sometimes you 
forget that you’re still the one controlling it.” Without accepting that responsibility and 
taking charge of self-management, the freedom is short-lived. 
Forgetting pump management essentials that required the user to count 
carbohydrates, enter the data, and to give an insulin bolus with food was a common and 
irritating occurrence for all participants. They found that if their BG was trending higher 
it was usually due to forgetting to bolus for carbohydrates.  “It’s not necessarily the 
pump’s fault. It’s the user’s fault . . . How do you forget to bolus? It’s right there on your 
hip!” (Lily). The reality was that life gets busy and distractions mount. Amy described a 
typical struggle as “I do forget, not like forget-forget . . . you keep going and going and 
you never really stop to think about anything.” However, it is the forgetting that is 
interrupted by the body’s alarm system as a response to hyperglycemia or “feeling 
horrible.” Keeping BG in the target range had a physical benefit: “You feel more 
energetic . . . more like yourself” (Amy). 
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BG monitoring before meals was also forgotten or just skipped with the emerging 
adult relying on “feeling” rather than self-monitoring by the glucose meter.  Even though 
alternate site testing was an available option, all participants chose finger sticks for BG 
readings which became tiresome, and were described as "it gets so old."  Relying on how 
one feels as opposed to relying on BG checks with a glucose meter was not uncommon. 
This was especially true when the emerging adult was around other people and thinking 
that “I can usually tell what range my blood sugar is in.” Forgetting to check BG levels 
was commonly discussed by participants, “honestly, sometimes, you just forget . . . your 
routine breaks.”  Forgetting was a struggle with the transition away from home without   
“constantly having Dad breathing down my neck and making [me].” Being willing to 
accept sole responsibility for the on-going daily tasks necessary for intensive self-
management was a challenging part of emerging adulthood. “Nagging” reminders to 
check BG still came from family and significant others. Anne reflected on her feelings 
about reminders to check her BG and bolus her insulin. 
 As a young adult in college, I hated [emphasis added] it. I thought my parents 
didn’t trust me. I resented them all the time for holding me accountable. . . Now I 
tend to appreciate it a little bit more. I get busy. I forget things sometimes . . . It’s 
funny how that changes over time . . . At 18, I couldn’t stand it.  . . I didn’t want 
people looking at my sugars. . . Things change over the years. 
Recognizing this is risky business: The wake-up calls. The reality of the risks 
associated with diabetes began to have an influence on acceptance of responsibility and 
self-care as the emerging adult tried to balance their way toward adulthood. Michelle had 
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parents in the health care field “who always pep talk me” telling her about complications 
they see in people with diabetes.  
[This] can be aggravating because I don’t want to hear about how I could lose my 
foot . . .  or what can happen if I don’t keep my sugar under control. But then 
sometimes it’s good because, you know, it’s part of life . . . it makes you think, 
okay, I really wouldn’t want that to happen to me (pause). I keep checking my 
sugar. 
Transitioning to university life from home-life often brought participants face-to-
face with the blunt realization that they were on their own. Burt reflected on his history of 
not accepting responsibility which resulted in numerous hospitalizations due to DKA. “It 
feels like you’re dying, literally. I tried to stand up and I couldn’t even move. That was 
scary.” After being told, “’If you don’t change what you’re doing, you’re going to be 
blind in about 10 years.’ That kind of woke me up. . . I don’t want to be blind.”   Lily 
shared her reality check during her first solo visit to her adult health care provider (HCP).  
It’s starting to hit me now . . . things that happen to my body and I don’t realize 
that the diabetes is damaging it. . . I’ve never had these complications. It was just 
kind of a wake-up call. I was just about to cry. . . I’ve got to take better control of 
this because it’s my responsibility, not my mom’s. . . I am on my own, kind of . . . 
it’s becoming more real now that I’ve got to take care of myself.  
Female participants saw the risks associated with pregnancy and poor glycemic 
control as significant concerns for their future. Reaching the necessary BG control before 
pregnancy seemed like an unreachable task but was considered something to be 
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addressed sometime in the future.  In their minds, that part of the tightrope lesson was for 
another day.  
Taking charge: A work in progress. Participants typically used the basic pump 
features that they learned with initial pump training. Fine tuning insulin delivery through 
the use of square wave and dual wave boluses and temporary basal rates was uncommon 
among these participants. Although some expressed the desire to learn more about their 
pump, they did not seek out advanced instruction. These emerging adults were not 
comfortable with or had not bought in to reviewing their BG data and making pump 
adjustments independently, and they left pump changes to their HCP. Greg did not make 
changes independently unless “it’s high just continually. I’ll [change] the basal a little bit 
because they told me to, but mostly I leave it up to the doctor. They go through my 
readings.”  
The paradox was, though, that this was a frequent source of tension with 
participants who felt HCPs made pump changes without taking into consideration other 
variables in their busy, non-routine lives. This was particularly challenging after their 
transition to adult care services that typically were perceived to lack the holistic approach 
of the pediatric diabetes team with which they were more familiar. “I don’t want my 
blood sugars to be high all the time or low all the time. But when you [the HCP] adjust 
stuff without looking at what’s actually going on or listening, it’s just kind of pointless,” 
(Amy). This point of passivity left the emerging adult wobbling on the high wire without 
optimal control. 
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Staying Connected: Is Anybody Out There? 
Having a secure safety net is critical for the tightrope walker. However, emerging 
adults with T1D and an insulin pump often felt that they were walking the tightrope alone 
and without a safety net. The period of emerging adulthood was a time when the safety 
net of their family, friends, and pediatric endocrinology team seemed no longer there to 
catch them. However, this time offered new opportunities to make important connections. 
Connecting with other pumpers. Living with diabetes, especially T1D with an 
insulin pump was often experienced alone. Most of the participants knew no other person 
with an insulin pump prior to receiving their pump, except for the three who attended a 
summer diabetes camp as a child. This daily sense of aloneness was common on a 
personal level and was compounded as participants, in their quest to be “normal,” tried to 
hide their insulin pump from the view of others. Anne shared her experience of seeing 
someone at a pump training meeting who had attended her high school. The two were 
unaware that they both had insulin pumps during their high school years. Hannah did not 
know anyone in high school with a pump, but since starting college she was pleased to 
meet two others with insulin pumps through her church.  
We’re like, ‘how’s your blood sugar?’ You know, we’ll joke about it. It’s a lot 
more, kind of reassuring, that other people are going through it too, you know. So 
you don’t feel as weird . . . you feel kind of normal.  
One young woman who was feeling the stress of being on her own in college 
without knowing  anyone else with a pump was recently able to connect to other 
pumpers through blogs.  
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Those are really encouraging. I love [emphasis added] those . . . I’m always like, I 
know what that feels like! That happens to me! So it’s really cool to kind of relate 
in that way. 
 She still longed for face-to-face support from others her age with pumps. In contrast one 
male participant stated the he did not “really need the support because I got it under 
control. I can do it myself.”   
Connecting with health care providers. Transitioning from home to college 
typically occurred about the time the emerging adult also separated from their pediatric 
endocrinologist. These participants were involved with pediatric endocrinology teams 
from five different southern states.  Most were very connected to their teams and voiced 
comfort, encouragement, and pleasure with their holistic and “up-to-date” health care 
experiences.  Fran described her interaction with the diabetes educator on the pediatric 
team.  
I looked forward to seeing her . . . she was positive . . . she gave tips on wearing 
the pump, losing weight, and what to eat for breakfast . . . we talked about clothes 
and shoes and other stuff besides diabetes. 
In contrast, the abrupt shift to adult care providers brought a sense of frustration. 
The clinic atmosphere and interactions lacked the “upbeat” feeling to which they were 
accustomed. As they encountered changes in providers and approaches to care, the 
emerging adult in the adult clinic felt a disconnectedness with the other patients in the 
waiting areas who were typically older type 2 patients and more debilitated.  Fran’s 
insight into this type of situation reflected wisdom in her young age, “even adult people 
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need that encouragement and that uplift and stuff. It’s hard to come by, I think, in an 
adult clinic.”  
In addition to these challenges of transitioning to adult care providers, the 
emerging adult often faced their first clinic visit alone without the benefit of a familiar 
person present on his or her behalf. Lily, age 23, described that experience through her 
tears. Although the nurse practitioner was very friendly, Lily faced a sense of panic when 
told they were going to do “ultrasound on her thyroid”.  
She didn’t tell me why we were going to do one. . . I’m just laying there. I was 
holding back tears. She’s like, ‘Are you okay? Your heart rate’s going so fast.’ 
I’m like, ‘No, I’m not okay.’  Then I just broke down. . . I’m thinking, ‘Do I have 
cancer? Am I gonna die?’ . . .  I didn’t know what was happening. . . I wanted to 
ask, but I really didn’t want to break down on them. . . They were just like, ‘Okay, 
it looks okay’ . . . well I’m still in panic mode. . . Next time I’m probably going to 
get my sister or my mom to go with me. . . even just to hold my hand. 
Not all experiences with adult clinic providers were negative. The need to connect 
to a HCP was important and that involved finding a good fit. Anne eagerly shared,  
I love my doctor that I’m with now. . . . Her nurse gave me her email and said, ‘If 
you ever need anything and you can’t reach me, here is my email address. Just 
feel free to email me for anything or any problems.’ 
Some participants found reassurance and comfort that came from connecting with a HCP 
who displayed an understanding approach and caring availability. 
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Accepting Me: Just a Part of Who I Am 
Becoming a well-balanced tightrope walker takes place over time after much practice 
and determination.  This process of becoming is also seen in the life of those using 
insulin pumps. Social vulnerability was an issue for some, but not all participants.  
You think people can see right through you and tell that you have [an insulin 
pump] or tell that you have diabetes. . . You expect everybody to see you as ‘not 
normal’ . . . For me, with my pump, I’ve learned to hide it very well, so nobody 
ever asks me anything. Nobody ever notices it unless I say something about it.  
(Anne)  
Amy, shared the tension of keeping her pump hidden because others might “think 
I am weird,” yet realizing it is “better that people knew.” Weighing the risks and benefits 
of exposure was part of what it meant to live with an insulin pump as an emerging adult. 
Attending university classes brought additional vulnerability as emerging adults faced 
different faculty and classmates in almost every course they attended.  While 
transitioning to college, Anne was “always terrified” that her pump would alarm, vibrate, 
and light up during class or when talking with someone who was unaware of her pump, 
but she acknowledged that having the pump actually made it much easier to “pull out my 
machine and check real quick instead of making a big scene." 
Feeling normal again. The quest for normalcy was evident in the lives of these 
emerging adults. Some expressed that they have achieved a sense of comfort and 
normalcy while others continued to seek it.  An insulin pump provided the ability to have 
a flexible lifestyle like others their age. “[Having the pump] made me feel normal again. 
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I’m like everybody else” (Jim).  Having the pump visible to others was difficult for some, 
not an issue to others. Burt shared,  
I was self-conscious about [the pump] at first . . . I was like, ugh, people will see 
it . . . but [going to diabetes camp] really got me out of my shell . . . It’s so normal 
now. It’s like telling someone I got a new tattoo. . . it’s just a part of me. 
 Acceptance was a process with the pump eventually accepted as just a part of who they 
are.   
Finding purpose. Several participants had progressed from being unable to talk 
to people about diabetes and their pump to being eager to share, teach, and encourage 
others. “I can use [my pump experience] to help other people rather than being bitter 
about it. . . it’s part of my life” (Lily). As some participants neared graduation and looked 
back over their experiences with diabetes, they were able to see how their openness about 
the pump and diabetes may be helpful to others they may encounter in the future. One 
young student teacher incorporated teaching plans that dealt with potential health 
emergencies in the classroom. Looking for purpose was a way of validating meaning. 
While holding on to a cautious hope for a cure, one participant reflected, “maybe I’m 
supposed to have it (pause) for somebody else down the line” (Hannah).  
These four themes represent the learning-while-living process that is experienced 
during the often unsteady tightrope walk between adolescence and adulthood for 
someone with an insulin pump. These themes intertwine with van Manen’s existentials of 
time, space, body, and relationships. The emerging adult with an insulin pump 
experienced lived time with the never ending requirements of checking BG, bolusing 
insulin, and regularly changing the infusion set within the context of multiple competing 
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demands on their time. Living with an insulin pump through the emerging adulthood 
period meant progressing over time toward acceptance of responsibility for diabetes self -
management along with being prepared to deal with the vulnerabilities of hypoglycemia 
and hyperglycemia. The emerging adult’s lived body faced the real or perceived stares of 
others as they often struggled with the need to keep the pump hidden until they were able 
to reach a point of acceptance of the pump as part of who they are. With T1D they were 
not able to live with their bodies in a state of self-forgetfulness. Instead diabetes required 
on-going BG monitoring and the negative consequences that accompanied the impact of 
low and high BG on their bodies. Lived space was felt as the emerging adult moved from 
the comfort of their home environment to a new and changing university or work 
environment without the safety net of those who were familiar with their diabetes and 
pump. The limitations of physical space on the body presented an additional challenge as 
the emerging adult must regularly move the pump’s infusion set to maximize 
effectiveness and to minimize physical harm. Some had the additional challenge of 
desiring to keep the pump hidden from view. All participants were in a continual search 
for a “good spot” to insert their pump. Lived relationships for the emerging adult were 
often enhanced by the flexibility and freedom associated with the insulin pump that 
allowed them to lead a fairly normal university life experience often driven by last minute 
plans and time spent in activities with an ever-changing group of people. Although the 
emerging adult had the freedom to be a part of the “normal” university and work world, 
living with the pump often carried a sense of traveling through this pump journey with an 
initial sense of aloneness until new connections are made with other pump users. 
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Metaphorical Description of Findings 
The use of metaphors and the language of poetry often speak to the reader and 
provide an additional means to reflect on the phenomenon of study (van Manen, 1990). 
This excerpt from The Tightrope Walker communicates the perspective of the emerging 
adults in this research.  
I look around me, and feel alone. 
Like a tightrope walker, 20 meters above his public. 
Every one watches, still he is alone. 
From the safeness of the ground the public cries 
Lean left! Lean right! 
Go forwards! Take a step back! 
Everyone knows how to help the tightrope walker. 
But no one knows the wind that blows 
Or the tension of the rope.  
No one knows all facts, but the tightrope walker himself 
I am a tightrope walker. 
 
From The Tightrope Walker posted by duncanrust May 14, 2007 
Discussion 
This study unveils the everyday experience of emerging adults living with T1D 
and insulin pumps. These emerging adults often begin to live away from their family, 
have multiple changes in living arrangements, and switch from their familiar pediatric 
health care teams to a new adult care service. Four strategies were identified as part of the 
process of maintaining their balance during this period from adolescence to adulthood: 
seeking control, becoming responsible, staying connected, and accepting me.  
Theme 1: Seeking Control 
This study found insulin pump technology to be particularly suited for the 
lifestyle and competing demands of emerging adults as they faced  what are typically the 
years of poorest glycemic control (Bryden et al., 2001; Insabella et al, 2007). Living with 
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an insulin pump as an emerging adult brought the possibility of improved BG control as 
well as freedom and flexibility that allowed them to regain some control of their everyday 
lives. Encouraging emerging adults to embrace a sense of control over their diabetes has 
the potential to impact their metabolic control. Aberle et al. (2009) found high internal 
locus of control associated with better glycemic control in adults with T1D who use 
insulin pump technology.  
The frustration these participants experienced when dealing with the negative 
impact of physical and psychosocial demands on glucose control mirrored similar 
findings with diabetes self-management in university students in the northeast US and the 
United Kingdom. (Ramchandani et al., 2000; Balfe, 2009). Although Peters and Laffel 
(2011) report feelings of invulnerability in the early years of emerging adulthood, these 
participants came face to face with physical, social, and emotional vulnerability. This 
vulnerability was especially frightening when the participants experienced a lack of 
control that resulted from severe hypoglycemia or unexplained hyperglycemic excursions 
without the safety net of family around them. This is a more vulnerable group because it 
has been shown that persons between the ages 20-29 living with T1D are four times more 
likely to die than their peers without diabetes (Rapley & Davidson, 2010).  
Deciding where to place the insulin infusion set was one area of control that the 
emerging adult in this study could claim. It was their decision to expose or hide their 
insulin infusion. Although not specific to insulin pump users, Dovey-Pearce, Doherty and 
May (2007) also found it important for young people to have control over disclosure of 
their diabetes to others. Those who attempted to keep the pump invisible to others and in 
a comfortable location reported struggling with the difficulty of “finding a good spot.” 
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This often resulted in these emerging adults delaying infusion set changes beyond the 
recommended 2-3 days.  
Theme 2: Becoming Responsible 
Findings from this study support Arnett’s (2001) work that accepting 
responsibility is a process that occurs over time for the emerging adult. In spite of sudden 
wake-up calls that they are now “on their own,” the emerging adult with an insulin pump 
must learn to plan ahead, have back-up supplies available, remember to check BG, count 
carbohydrates, and bolus insulin doses as they learn to adjust to the irregular routines of 
college life (Balfe, 2009). This process of becoming responsible often comes from 
“learning the hard way.” Sparud-Lundin, Ohrn & Danielson, (2009) found this shift in 
responsibility for self-management was also a struggle for many parents who have to 
learn to step back in their own routine. No empiric data is available that addresses the 
self-efficacy of making pump changes in emerging adults. For these participants, taking 
responsibility for fine-tuning their insulin pump for improved glucose control was still a 
work in progress as most participants left the responsibility for pump adjustments with 
their HCP.  
Theme 3: Staying Connected 
A support network is necessary in the face of the continuous demands of diabetes 
self-management (Scott et al., 2005) and the role of peer support was found to increase 
during the adolescent years (Dovey-Pearce et al., 2007; Pendley et al., 2002). Although 
parents were often considered to be nagging during the adolescent and emerging adult 
years, these participants, as did participants in Dovey-Pearce et al. (2007) had times that 
they relied on the “safe base” of the family. After leaving home, these emerging adults 
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faced the loss of daily connections with family and friends who were familiar with their 
diabetes.  
Markowitz and Laffel (2012) identified the need for emerging adults to discuss 
issues of daily living with others who are facing similar daily demands. Such support 
group connections had a positive impact on self-management and metabolic control. Only 
one participant in this study had regular face-to-face encounters with other pump users. 
Not knowing others their age with T1D and/or insulin pumps and a perceived lack of 
social support networks has been a finding in other studies (Kay et al., 2009; Perry et al., 
2012).  
As the emerging adult lost immediate family support with a move from home, 
they typically faced an abrupt switch from their familiar pediatric endocrinology team to 
a new adult HCP. This critical period of transition from pediatric to adult care providers 
for T1D is beginning to receive attention. Garvey et al. (2012), in the first study of the 
transition care experience for emerging adults with T1D in the US, found the mean age of 
transition to adult care was 19.5 years and fewer than half of those were given contact 
information for an adult HCP prior to “transition.” Gaps in care of > 6 months after 
leaving a pediatric care team have been identified in up to 40% of emerging adults 
(Daneman & Nakhla, 2011; Pacaud et al., 2005; van Walleghem, MacDonald & Dean, 
2008). Several participants in this study felt frustration with the change in adult health 
care provider practices after losing their connection to a holistic pediatric care team. 
Participant’s self-reported health care visits over the previous year, from endocrinologist 
to ophthalmologists, ranged from one HCP visit to seven visits. 
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Theme 4: Accepting Me 
The emerging adult years are a time for identification of who one is as an 
individual as well as who they are as part of a community (Arnett, 2001; Arnett, Ramos 
& Jensen, 2001; Schwartz et al., 2011). The experience of emerging adults with T1D and 
insulin pumps in this study suggest the quest for a sense of normalcy.  Consistent with 
findings of Kay, et al., 2009, most participants expressed concerns about being viewed as 
different or “weird” and often tried to keep their insulin pump hidden from the view of 
others. Although Dovey-Pearce, Doherty and May (2007) reported a shift in personal 
identity that seemed to take place before those newly-diagnosed with diabetes left the 
hospital, participants in this study demonstrated a self-acceptance of life with T1D and a 
pump as a process that occurs over time. Most participants gained a sense of acceptance 
as the pump eventually became a part of who they are, described by one young man as 
being just like “a new tattoo.”  
Limitations 
Several limitations to the study must be acknowledged. First, all participants were 
non-Hispanic white (NHW). Although T1D impacts a disproportionately large number of 
NHW youth, this study included no participants from other races. Second, demographic 
data from hemoglobin A1C to HCP visits over the past year were self-reported. Third, 
while this study has implications for emerging adults with T1D who have an insulin 
pump, the sample was derived from a 200 mile radius of the north-central part of 
Louisiana. It is not known if this population has different experiences from those who 
live in other parts of the US or who live internationally.  
 
52 
 
Implications for Practice 
The findings of this study support Arnett’s model of emerging adulthood and  
provide empirical support for the design and implementation of transition services for the 
emerging adult with T1D. Understanding the challenges and frustrations of desiring 
control of their life and their blood sugar amidst multiple competing demands is essential 
and comes through attentive listening to these emerging adults who are much more than 
BG numbers on a pump. It is important that the HCP recognizes that accepting 
responsibility for the endless demands of self-management is a process that occurs over 
time and involves on-going negotiations and open communication between the emerging 
adult, the parent and/or significant other, and the adult health care team as the bulk of 
responsibility shifts to the emerging adult. It is also vital to understand the emerging 
adult’s need to connect in a period of time when there is often a sense of going through 
the diabetes journey alone.  
This understanding opens the possibility of development of assessment tools and 
resources with the input of emerging adults. These resources should address specific 
needs such as glycemic control issues encountered with changes in routine at the start of 
a new semester or during final exams, relationship changes, or a change in residence. 
Attention to the developmental concerns of this developmental period such as career 
preparation and intimacy issues are important as well. Likewise, asking emerging adults 
about their support network can help the provider identify ways to connect them with 
others through university groups such as Students with Diabetes or College Diabetes 
Network, through blogs, or through community groups or groups within their own 
practice. Services with such social components can encourage increased responsibility, 
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provide support, and promote acceptance. The Maestro Project (van Walleghem, 
MacDonald & Dean, 2008) is an intervention built on this need for connection with peers 
and with HCPs and has been used in Canada to decrease the number of emerging adults 
lost to follow-up care. This model is designed to facilitate relationships at a time when 
they are critically needed by a vulnerable population.  
Collaborative goal setting with their HCP is a way to provide the emerging adult 
with a sense of control as well as to promote a growing sense of responsibility for their 
diabetes self- management (Haas et al., 2012; Scott et al., 2005). If emerging adults 
perceive adult care providers lack understanding of what is going on in their lives  and 
make arbitrary changes that seem to just increase their insulin, this sense of disconnect 
may have a negative impact on their clinic visits at a time when they are most vulnerable. 
Conclusions 
Understanding the unique challenges and strategies of the emerging adult will 
assist HCPs as they design and implement evidence based, patient-centered care 
practices. Although this age group may seek control, accepting responsibility when 
abruptly facing the realization that “I am on my own” is a process that takes time. The 
emerging adult years can be considered a period of gradual acceptance of the on-going 
responsibilities and consequences associated with the everyday demands of diabetes 
management with an insulin pump. Recognizing the need for this age group to connect 
with others at similar points in the diabetes journey, the HCP needs to consider strategies 
that link the younger adult population through creative scheduling possibilities and 
communication strategies that consider the needs and preferences of this age group.  
Through a plan of care designed for this group that is no longer an adolescent but not yet 
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an adult, HCPs can assist the emerging adult through this vulnerable period with the tools 
and confidence necessary to successfully continue their journey. 
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Chapter 4 
Summary and Conclusion 
Evaluation of the Project 
The purpose of this research was to gain a deeper understanding of the experience 
of emerging adults using insulin pumps for diabetes self-management. Understanding the 
lived experience through phenomenological interpretation gives a voice to this group that 
has often been overlooked at a critical point in their life journey with diabetes. Through 
in-depth, face-to-face conversations, participants were able to share their descriptions of 
what it feels like to wear an insulin pump during the emerging adult years. Four themes 
were identified as essences of their experience between adolescence and adulthood: 
seeking control, becoming responsible, staying connected, and accepting me. These 
essences were ultimately viewed as strategies used by the emerging adult as they 
journeyed through their adolescent and young adult years while living with T1D and an 
insulin pump.  
A challenge of this research was locating potential participants with insulin 
pumps in this specific age group. Purposive sampling was used to find participants 
willing to share the details of their experiences. It was anticipated that snowball sampling 
would assist with the identification of potential participants. Because a common finding 
was the sense of being alone as a pumper, the participants had very limited knowledge of 
any other pump users in this age group. As a result, the interview portion of this study 
required six months. A limitation of this study comes from having all participants being 
non-Hispanic white currently living in the state of Louisiana. No emerging adults of other 
races were identified. Although these participants received pediatric endocrinology care 
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varying from small clinics to large Children’s Hospital centers from four different states, 
their emerging adult years were within a 200 mile radius of north Louisiana. Thus 
generalizability of these findings is limited. 
Recommendations Based on the Findings 
The findings of this research clearly indicate how critical it is for health care 
professionals (HCPs) to recognize the importance of the emerging adult having control 
over their lives. Along with the desire for glycemic control that allows individuals to feel 
their best physically, the emerging adult seeks the opportunity to feel in control of their 
daily lives. The opportunity to actively partner with HCPs in care decisions is one way to 
promote a sense of control. However, the findings also demonstrate that accepting 
responsibility for diabetes self-management with an insulin pump during these years of 
transition to independent living is a process that takes time. In the midst of multiple 
competing demands it may be unrealistic for the HCP to expect the emerging adult to 
suddenly transition to an adult care practice and accept the responsibilities of a typical 
adult pump patient.  
It is important to note that emerging adults are working their way through these 
demanding years without the comfort of their familiar safety net. It is not uncommon for 
this age group to feel a sense of aloneness during their diabetes journey. Recognizing this 
need and facilitating opportunities for connections with other pumpers may be a strategy 
with promise for improving glycemic control, encouraging responsible self-management, 
and promoting a sense of normalcy.  
Findings gleaned from this study pave the way for future research that that targets 
the development and evaluation of interventions and resources specifically designed for 
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the emerging adult population. Research that focuses on the transition from health care in 
a pediatric practice setting to the adult care setting is also needed. The inclusion of 
emerging adults in the design and evaluation of support resources, such as campus 
organizations for students with diabetes, blogs, social media applications is essential. 
Interventionals studies can follow that measure the impact of these tools on self-
management, glycemic control and quality of life for this age group.  
 Two related areas for future research are with parents of emerging adults. 
Understanding the experience of “letting go” may be useful for both the parent and 
emerging adult. Additional research is also needed addressing the preconception and 
perinatal experiences of young women with T1D and insulin pumps from perspectives of 
these young women, their significant others, and the nurses caring for them.  
Conclusion 
Understanding the self-management practices of emerging adults with insulin 
pumps in the context of daily living is critical for the development of practice guidelines 
and resources that are developmentally appropriate for this group of insulin pump users. 
Recognizing the typical demands of this age group is necessary in the development of a 
framework of care that can effectively meet their needs. Major findings from this study 
reveal the importance of gaining control, the process of becoming responsible, the need 
for connection with others, including the HCPs, and the hope of acceptance that can come 
with time and support for the emerging adult with T1D.  
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Appendix B 
The University of Texas at Tyler Institutional Review Approval 
The University of Texas at Tyler 
Institutional Review Board 
 
October 6, 2011 
 
Dear Ms. Hood: 
Your request to conduct the study entitled The Nature and Meaning of Insulin Pump 
Use in Emerging Adults is approved as an expedited study, IRB #F2011-14 by The 
University of Texas at Tyler Institutional Review Board. This approval includes the use of 
the written informed consent that is attached to this approval letter. Please use this form 
for all persons, and ensure that each participant is able to repeat the purpose of the 
study, the voluntary nature of it, any risks involved, and who to contact other than you as 
the PI. In addition, ensure that any research assistants or co-investigators have 
completed human protection training, and have forwarded their certificates to the IRB 
office (G. Duke).  
Please review the UT Tyler IRB Principal Investigator Responsibilities, and 
acknowledge your understanding of these responsibilities and the following 
through return of this email to the IRB Chair within one week after receipt of this 
approval letter:  
 
 This approval is for one year, as of the date of the approval letter 
 Request for Continuing Review must be completed for projects extending past 
one year 
 Prompt reporting to the UT Tyler IRB of any proposed changes to this research 
activity 
 Prompt reporting to the UT Tyler IRB and academic department administration 
will be done of any unanticipated problems involving risks to subjects or others 
 Suspension or termination of approval may be done if there is evidence of any 
serious or continuing noncompliance with Federal Regulations or any aberrations 
in original proposal. 
 Any change in proposal procedures must be promptly reported to the IRB prior to 
implementing any changes except when necessary to eliminate apparent 
immediate hazards to the subject.  
 
Best of luck in your research, and do not hesitate to contact me if you need any 
further assistance. 
 
Sincerely, 
 
 
Danita Alfred, PhD, RN 
Member, UT Tyler IRB 
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Appendix C 
Informed Consent Form 
Informed Consent Form THE UNIVERSITY OF TEXAS AT TYLER 
Informed Consent to Participate in Research 
Institutional Review Board # F2011-14 
Approval Date: 10-06-11 
1. Project Title: The Nature and Meaning of Insulin Pump Use in Emerging 
Adults  
2. Principal Investigator:  Donna G. Hood 
 
3. Participant’s Name:   
 
To the Participant:   
 
You are being asked to take part in this study at The University of Texas at Tyler 
(UT Tyler). This consent form explains why this research study is being 
performed and what your role will be if you choose to participate. This form also 
describes the possible risks connected with being in this study. After reviewing 
this information with the person responsible for your enrollment, you should be 
able to understand and make an informed decision on whether you want to take 
part in this study. 
 
4. Description of Project 
The purpose of this study is to learn more about what it means to use an 
insulin pump from the view of individuals using an insulin pump to manage type 1 
diabetes. You are being asked to take part in this study because you have type 1 
diabetes, you use an insulin pump, and you are between ages 18 – 25. 
 
5. Research Procedures   
 
If you agree to be in this study, we will ask you to do the following things: 
 Decide on an interview location that is comfortable for both yourself and 
Donna Hood. 
67 
 
Appendix C (Continued) 
 
 Pick a different name (pseudonym) to be used during the interview so that 
no one reading or hearing your interview information, other than Donna 
Hood, will know your real name. 
Answer some written questions about yourself and your diabetes/insulin 
pump history (demographic questionnaire). This will include your age, 
race, how long you have had diabetes, if you work or attend school, your 
last HgA1C, and your type of medical provider(s). 
 Participate in at least one interview between yourself and Donna Hood 
where you will be asked questions about your experiences with your 
insulin pump. 
 Allow the interview to be recorded by an auditory-recording device. You 
may ask to stop the recording at any time and the recording will be 
stopped. 
 Face-to-face interviews are expected to last about one hour, but you may 
stop the interview at any time. 
 Follow-up interviews may be requested and can be held in person, by 
phone, or by computer-assisted communication. 
 Some quotes from your interview may be used in write-ups and 
presentations about this research study, but your real name will never be 
used. 
 
6. Side Effects/Risks   
The interviews may cause uncomfortable feelings from sharing any 
stressful experiences related to your experiences of living with your insulin 
pump. Again, the interview can be stopped by you at any time and you 
can choose not to answer any questions. 
 
7. Potential Benefits  
Your taking part in this study may include the benefit of knowing that 
sharing of your story may help bring about better care for others with 
diabetes. You may also gain a deeper understanding of your experience 
with your insulin pump.  
 
Understanding Of Participants 
8. I have been given an opportunity to ask any questions concerning this 
research study and the researcher has been willing to answer my 
questions.  
 
9.  If I sign this consent form I know it means that: 
 I am taking part in this study because I want to. I chose to take part in this 
study after having been told about the study and how it will affect me. 
 I know that I am free to not participate in this study and that if I choose to 
not participate, then nothing will happen to me as a consequence. 
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 I know that I have been told that if I choose to participate, then I can stop 
being a part of this study at any time. I know that if I do stop being a part 
of the study, then nothing will happen to me. 
 I will be told about any new information that may affect my willingness to 
continue participating in this study. 
 The study may be changed or stopped at any time by the researcher or by 
The University of Texas at Tyler. 
 The researcher will gain my written consent for any changes that may 
affect me. 
 
10. I have been assured that my name will not be revealed in any reports or 
publications resulting from this study without my expressed written 
consent.  
 
11. I also understand that any information collected during this study, 
including any health-related information, may be shared with the following 
as long as no identifying information as to my name, address, or other 
contact information is provided): 
 
 Organization contributing money to be able to conduct this study 
 Other researchers interested in combining your information with 
information from other studies 
 Information shared through presentations or publications 
 
12. I understand The UT Tyler Institutional Review Board (the group that 
ensures that research is done correctly and that measures are in place to 
protect the safety of research participants) may review documents that 
have my identifying information on them as part of their compliance and 
monitoring process. I also understand that any personal information 
revealed during this process will be kept strictly confidential.  
 
13. I have been told of and I understand any possible expected risks that are 
associated with my participation in this research project.   
 
14.  I understand that I will not be compensated for any patents or discoveries 
that may result from my participation in this research. 
 
15. If I have any questions concerning my participation in this project, I shall 
contact the principal researcher: Donna Hood, at (318) 548-8045, 
dhood3@patriots.uttyler.edu 
 
17. If I have any questions concerning my rights as a research subject, I shall 
contact Dr. Gloria Duke, Chair of the IRB, at (903) 566-7023, 
gduke@uttyler.edu, or the University’s Office of Sponsored Research:  
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The University of Texas at Tyler 
c/o Office of Sponsored Research 
3900 University Blvd 
Tyler, TX  75799 
 
I understand that I may contact Dr. Duke with questions about research-
related injuries. 
 
18. CONSENT/PERMISSION FOR PARTICIPATION IN THIS RESEARCH 
STUDY 
 
Based upon the above, I consent to taking part in this study as it is 
described to me. I give the study researcher permission to enroll me in this 
study. I have received a signed copy of this consent form. 
 
_____________________________   _ ___  _ __________     _________ 
Signature of Participant Date 
_____________________________________  
Witness to Signature  
19. I have discussed this project with the participant, using language that is 
understandable and appropriate. I believe that I have fully informed this 
participant of the nature of this study and its possible benefits and risks. 
The participant was able to understand that this is a research study. 
He/she was able to describe basic purpose of the study; the risks 
involved; their role and approximate time commitment; the voluntary 
nature of participation; and who to contact other than the researcher if  
 they have comments or questions about the study.  I believe the 
participant understood this explanation. 
 
 
 _________________________________ _______________ 
 Researcher/Principal Investigator     Date 
 
Pseudonym_______________________________________________ 
If I have your permission to contact you again in order to clarify or 
confirm your interview information, please provide your preferred contact 
information here: 
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Demographic Questionnaire 
Pseudonym _____________________________________________ 
1. Age:_________________________ 
2. Race:    ________________________ 
3. Gender:___________________ 
 
4. Number of years since diagnosis of type 1 diabetes:___________________ 
 
5. Years (or months) of pump use:___________________ 
 
6. Do you currently work or attend school?Check all that apply. 
 Work full time _________ 
 Work part time _________ 
 Student full time_________ 
 Student part time_________ 
 
7. What describes your current living arrangements? 
 Live in home with parent/parents_________ 
 Live in home with extended family_________ 
 Live in university housing with roommate (s)_________ 
 Live alone_________ 
 Live in apartment with roommate (s)_________ 
 Other (describe)___________________________ 
 
8. How many hours per week do you typically spend in vigorous physical 
activity? 
 ___________ 
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9. How many hours per week do you typically spend in moderate physical 
activity? 
 __________ 
  
10. Last HgA1C_________ 
 
11. Type(s) of medical provider(s) you have seen at least once in the last year:  
Check all that apply. 
 
 Endocrinologist/ Diabetologist_________   adult/pediatric/adolescent 
 Diabetes Educator_________ 
 Pump Specialist/Trainer_________ 
 General practice physician_________ 
 Internal medicine physician _________ 
 Nurse practitioner_________ 
 Registered Dietitian_________ 
 Gynecologist_________ 
 Psychologist_________ 
 Ophthalmologist/Optometrist_________ 
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Interview Guide  
Probes: How did/does that feel? What was that like?  What does that mean to you? 
 
1. What is it like to wear an insulin pump as a ____ year old? Tell me your story. 
2. When did you first go to a pump? What was that experience like? 
3. Tell me what it was like going from your high school days with a pump to 
university life . . . and now. 
 
4. Describe your experience going from a pediatric endocrinologist to an adult care 
provider? 
 
5.What has been the impact of your pump on your self-management? 
6. What has been your experience as a pump wearer when you think about your 
interactions with other people? (roommates, friends, dates, faculty, employers, 
parents/family) 
 
7. Do you ever find yourself manipulating your pump to . . . change something? 
8. Tell me what it is like to deal with lows? High blood glucose? 
9. What has been your biggest challenge with self management and/or your pump? 
Your biggest success? 
 
10. If you were to give your pump experience a word or phrase – “Using this pump is 
____” what would it be? 
 
11.When you think about the future, what goes through your mind? 
12. What else do you want to share anonymously with other people? “I think ______ 
need to know that . . .” 
 
13. As we conclude, how do you feel about being a part of this study? 
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Example of Lifeworld Existential Analysis 
Amy #1 Contextual Analysis 
Amy is a 20 year old full time student who also works part time. She lives about an 
hour from home in an apartment with her roommate. She has had diabetes for 9 years and 
her pump for 8 years. Her last A1C was 6.1 and she has seen several HCPs over the past 
year.  
Narrative on Meaning for Amy 
Temporality- Time is a big component of the insulin pump experience for Amy. 
Before the pump her day was defined by time schedules for insulin injections and rigid 
eating times. Time continues to play a big role in her experience, now with the blessing 
of flexibility of time that we take for granted. The pump allows what she calls “temp 
basals” those multiple different patterns of insulin delivery that she has control over thus 
giving her much more control of her time. As a busy university student this is particularly 
important as she must adjust to changing and demanding schedules that include marching 
band, classes, and her social life. Diabetes still requires attention to time, but she finds 
she is dropping those programmed pump alarms that reminded her to check BG or change 
her infusion site because they are annoying when they go off during class. Time still has 
its challenges as Amy gets caught up in the “business of life” and forgets to check her BG 
or tell her pump to deliver insulin for her food. Time often slips by and she realizes that 
she forgot and that brings a cost that takes a toll on her body. 
Corporeality – Amy’s body is dependent on exogenous insulin from her pump 
requiring her to check her BG regularly, count carbs, and interact with the pump in order  
74 
 
Appendix F (Continued) 
to maintain normal BG. Normal BG gives her a calmer yet more energetic feel in her 
body. With high BG she gets frustrated easier, is tired, and doesn’t feel as well. With low 
BG she gets shaky, flustered, and can’t think straight. Normalizing BG makes her feel 
herself again. Self-management of her diabetes requires “stabbing” her fingers to check 
BG and changing her pump site about every three days. There are certain places on her 
body she can insert her pump (abdomen, thigh, hip) depending on adequate fatty tissue, 
access, and comfort. Since going to college she typically uses her abdomen for her 
insertion set and keeps her pump hidden in her bra to avoid questions and having it pulled 
out by the tubing. When she clips her pump to her waist or something, seeing it or having 
her hand brush up against it serves to remind her that it is there. Weight gain has not been 
an issue. 
Spaciality – Lived space for Amy varies. She is an hour away from home and lives in 
a university apartment on the third and fourth floors. She has found this challenging when 
she has low BG and must get to a glucose source and has had to call her brother to come 
to apartment to help her. Although the pump has many advantages over insulin injections, 
Amy finds it “awkward” and “annoying” when she feels like she must step away to deal 
with a beeping pump during class or to program the pump with her carb count when out 
with friends.  
Relationality – The experience with others continues to be challenging for Amy as 
she is torn between not wanting others to know she has a pump (“they might think I’m 
weird” or feeling “awkward” when explaining) to feeling like it is better when people 
around her know about her diabetes. That curiosity of others is uncomfortable. With 
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those who know about her diabetes, their reminders also bring a sense of struggle as she 
vacillates between thinking that sounds like her Dad hounding her with “overbearing” 
reminders to  check her BG and if she is okay to being grateful that others around her 
care. Amy doesn’t feel restricted in her social life other than having to answer questions 
and not really wanting to. 
 
Holistic Reading for Amy 
Insulin pump use means freedom from a rigid structure of life which is really 
important as a university student. With the freedom comes a struggle of wanting to take 
control on her own but facing the business of life that leads to forgetting and frustration.  
Ultimately, she has to decide for herself that she will take control.  
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